Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Pozzilli

Showing results (171-180 of 247) with videos related to

Pageof 25
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 6, 2013
Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patientsMassimo Filippi, Maria A Rocca, Stefano Bastianello, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 24, 2009
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experienceAngelo Ghezzi, Maria Pia Amato, Pietro Annovazzi, et al.
Journal of Neurology|February 18, 2016
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systemsAnna Maria Bargagli, Paola Colais, Nera Agabiti, et al.
Neuroepidemiology|August 10, 2017
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, ItalyPaola Colais, Nera Agabiti, Marina Davoli, et al.
Journal of Neurology|April 9, 2025
Clinical and MRI features contributing to the clinico-radiological dissociation in a large cohort of people with multiple sclerosisAbhineet Ojha, Silvia Tommasin, Claudia Piervincenzi, et al.
Annals of Neurology|March 3, 2023
Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum DisorderSean J Pittock, Michael Barnett, Jeffrey L Bennett, et al.
Journal of Neurology|March 25, 2026
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension studyXavier Montalban, Reinhard Hohlfeld, Carlo Pozzilli, et al.
Frontiers in Neurology|August 6, 2019
Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferioritySilvia Romano, Michela Ferraldeschi, Francesca Bagnato, et al.
European Neurology|February 1, 2014
From high- to low-frequency administered interferon-beta for multiple sclerosis: a multicenter studyLuca Prosperini, Chiara Rosa Mancinelli, Carlo Pozzilli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2015
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridineRichard Macdonell, Guy Nagels, David-Axel Laplaud, et al.
Pageof 25

Showing results (171-180 of 247) with videos related to

Sort By:
Pageof 25
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 6, 2013
Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patientsMassimo Filippi, Maria A Rocca, Stefano Bastianello, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 24, 2009
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experienceAngelo Ghezzi, Maria Pia Amato, Pietro Annovazzi, et al.
Journal of Neurology|February 18, 2016
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systemsAnna Maria Bargagli, Paola Colais, Nera Agabiti, et al.
Neuroepidemiology|August 10, 2017
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, ItalyPaola Colais, Nera Agabiti, Marina Davoli, et al.
Journal of Neurology|April 9, 2025
Clinical and MRI features contributing to the clinico-radiological dissociation in a large cohort of people with multiple sclerosisAbhineet Ojha, Silvia Tommasin, Claudia Piervincenzi, et al.
Annals of Neurology|March 3, 2023
Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum DisorderSean J Pittock, Michael Barnett, Jeffrey L Bennett, et al.
Journal of Neurology|March 25, 2026
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension studyXavier Montalban, Reinhard Hohlfeld, Carlo Pozzilli, et al.
Frontiers in Neurology|August 6, 2019
Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferioritySilvia Romano, Michela Ferraldeschi, Francesca Bagnato, et al.
European Neurology|February 1, 2014
From high- to low-frequency administered interferon-beta for multiple sclerosis: a multicenter studyLuca Prosperini, Chiara Rosa Mancinelli, Carlo Pozzilli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2015
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridineRichard Macdonell, Guy Nagels, David-Axel Laplaud, et al.
Pageof 25